Boehringer Ingelheim

C.H. Boehringer Sohn AG & Co. KG
Company typePrivate
IndustryPharmaceuticals
Founded1885 (1885) in Ingelheim am Rhein, Germany
FounderAlbert Boehringer
Headquarters,
Germany
Area served
Worldwide
Key people
  • Hubertus von Baumbach (chairman of the board)
  • Michael Schmelmer (vice chairman)
  • Carinne Brouillon (board member)
  • Shashank Deshpande (board member)
  • Paola Casarosa (board member)
  • Frank Hübler (board member)
ProductsPharmaceuticals and Animal Health
Revenue €26.8 billion (2024)
OwnerBoehringer, Liebrecht and von Baumbach families
Number of employees
54,500 (2024)
Websiteboehringer-ingelheim.com

C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one.

Headquartered in Ingelheim, it operates globally with more than 54,000 employees in 78 countries. Unlike most large pharmaceutical companies which are listed, the company is private and fully owned by the Boehringer, Liebrecht and von Baumbach families. The company's key areas of interest are: respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system. Boehringer Ingelheim is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). The corporate logo of Boehringer Ingelheim depicts a stylized rendition of the central section of the imperial palace of Charlemagne.